Autolus Therapeutics plc has grown revenue 196% a year over three years and 161% a year over five. Revenue growth, 3-year annual rate: +196% (Biotechnology median +17%). Revenue growth, 5-year rate: +161%, growth has picked up over the last three years. Years of annual history on file: 10, FY2015 to FY2025, as filed.

AUTLAutolus Therapeutics plc

Healthcare

$1.77+18% 1Y

$1.77

$1.2152 weeks$2.54

Is it growing?

Good

Operating margin widening (+11221.6 points). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data

Margin direction+11221.6 points operatingSEC EDGAR · Jun 30, 2026

Trailing-twelve-month operating margin, -239.8% now against -11461.4% a year earlier.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AUTL growing?

Autolus Therapeutics plc has grown revenue 196% a year over three years and 161% a year over five.

+196%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +161%
Revenue growth, 5-year rate · +196% over three · growth has picked up over the last three years
Years of annual history on file: 10
Years of annual history on file · FY2015 to FY2025, as filed

Details›